Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 14, 2021

SELL
$212.27 - $248.7 $212,270 - $248,700
-1,000 Closed
0 $0
Q2 2020

Jul 10, 2020

SELL
$197.81 - $242.74 $4.33 Million - $5.31 Million
-21,894 Reduced 95.63%
1,000 $235,000
Q1 2020

Apr 13, 2020

SELL
$182.24 - $241.7 $32.6 Million - $43.2 Million
-178,613 Reduced 88.64%
22,894 $4.64 Million
Q4 2019

Jan 10, 2020

BUY
$189.21 - $243.2 $3.56 Million - $4.58 Million
18,838 Added 10.31%
201,507 $48.6 Million
Q3 2019

Oct 10, 2019

BUY
$174.11 - $208.62 $28,031 - $33,587
161 Added 0.09%
182,669 $35.3 Million
Q2 2019

Jul 24, 2019

BUY
$166.7 - $195.41 $2.12 Million - $2.49 Million
12,735 Added 7.5%
182,508 $33.6 Million
Q1 2019

Apr 10, 2019

BUY
$180.87 - $203.88 $6.4 Million - $7.21 Million
35,379 Added 26.32%
169,773 $32.3 Million
Q4 2018

Jan 24, 2019

BUY
$178.4 - $208.25 $1.69 Million - $1.97 Million
9,461 Added 7.57%
134,394 $26.2 Million
Q3 2018

Oct 10, 2018

BUY
$185.29 - $208.89 $1.37 Million - $1.54 Million
7,370 Added 6.27%
124,933 $25.9 Million
Q2 2018

Jul 13, 2018

SELL
$166.05 - $186.51 $1.26 Million - $1.42 Million
-7,593 Reduced 6.07%
117,563 $21.7 Million
Q1 2018

May 01, 2018

BUY
$169.43 - $198.0 $3.11 Million - $3.64 Million
18,371 Added 17.2%
125,156 $21.3 Million
Q4 2017

Feb 05, 2018

BUY
$168.79 - $188.59 $18 Million - $20.1 Million
106,785
106,785 $18.6 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Manning & Napier Group, LLC Portfolio

Follow Manning & Napier Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Group, LLC with notifications on news.